Epiness™ - Reinventing Epilepsy Management
EPINESS brings the power of AI and home monitoring to epilepsy management, providing accurate detection and prediction of seizures and helping patients live a better life.
Understanding Epilepsy
Epilepsy affects millions worldwide, with significant impact on quality of life and daily activities.
People worldwide live with epilepsy, making it one of the most common neurological disorders
Approximately one in three people with epilepsy have seizures that are not controlled by medications (drug-resistant epilepsy)
Higher risk of premature death in people with epilepsy compared to the general population
50,000 people with epilepsy die per year from SUDEP (Sudden Unexpected Death in Epilepsy)
Estimated annual global cost of epilepsy, including medical expenses and lost productivity
Of the epilepsy patients suffer from depression, underscoring the substantial impact on mental health and quality of life
Our Solution
Neurohelp's comprehensive epilepsy management system combines advanced signal processing with AI to provide both seizure detection and seizure prediction capabilities. Our system offers unprecedented accuracy and low latency, providing crucial time for intervention.
Seizure Detection
Our system achieves the lowest false alarm rates while maintaining high sensitivity, providing reliable monitoring for patients and caregivers. The advanced algorithms analyze brain activity patterns in real-time, ensuring accurate seizure detection.
Seizure Prediction
Beyond detection, our AI-powered system can predict potential seizures before they occur, giving patients and caregivers valuable time to prepare and take preventive measures.
Clinical Validation
Performance
- General Population - 75% seizure detection rate with 1 false alarm in 5 days
- Temporal Lobe Epilepsy Patients - Only 1 false alarm per month
- Tonic-Clonic Seizures - Able to detect with 92% success without false alarms
Clinical Trials
- Beilinson Hospital: Clinical validation of wearable device and detection algorithm including 30 patients (Started May 2025)
- Sheba Medical Center: Software evaluation using clinical EEG data including 100 patients (Started May 2025)
- Planned FDA Clinical Trials across multiple U.S. epilepsy clinics (Planned H2 2026)
Seize Control - Don’t Let Epilepsy Define You
Reach us and join our ongoing clinical trials or get the latest news on the development of Epiness™.
Book a Demo